By Huang Jianwen King&Wood Mallesons’ Investment Group
The National Health and Family Planning Commission (the “NHFPC”) and the China Food and Drug Administration (the “CFDA”) recently jointly published the Administration Measures for the Research (for Trial Implementation) (the “Administration Measures”), which became effective on 20 July 2015.
The Administration